Arcus Biosciences Inc. (RCUS)
NYSE · Healthcare
Arcus Biosciences Inc. Operating Income 2017–2025
Arcus Biosciences Inc. annual/quarterly operating income history and growth rate from 2017 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Arcus Biosciences Inc. operating income for the quarter ending March 31, 2026 was -134.0 M, a 9.84% increase year-over-year.
- Arcus Biosciences Inc. operating income for the twelve months ending March 31, 2026 was -406.0 M, a 32.25% increase year-over-year.
- Arcus Biosciences Inc. annual operating income for 2025 was -386.0 M, a 16.97% increase from 2024.
- Arcus Biosciences Inc. annual operating income for 2024 was -330.0 M, a 2.94% decrease from 2023.
- Arcus Biosciences Inc. annual operating income for 2023 was -340.0 M, a 21.43% increase from 2022.
- Arcus Biosciences Inc. annual operating income for 2022 was -280.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Arcus Biosciences Inc. Operating Income — FAQ
Arcus Biosciences Inc. (RCUS) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Arcus Biosciences Inc.'s operating income?
Arcus Biosciences Inc. (RCUS) reported operating income of -$386M for fiscal 2025.
Where can I see RCUS's operating income history?
The chart and table above show Arcus Biosciences Inc.'s operating income by year and by quarter, including the growth rate.